NASDAQ: LSTA - Lisata Therapeutics, Inc.

छह महीने के लिए लाभप्रदता: -21.67%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Lisata Therapeutics, Inc.


कंपनी के बारे में Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases.

अधिक जानकारी
Its product candidates include LSTA1, which is in Phase 1b/2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; HONEDRA, a recipient of SAKIGAKE designation critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and LSTA201, a CD34+ cell therapy for the treatment of chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

IPO date 1999-03-01
ISIN US1280583022
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.lisata.com
Цена ао 2.43
प्रति दिन मूल्य परिवर्तन: -2.51% (2.4104)
प्रति सप्ताह मूल्य परिवर्तन: -1.26% (2.38)
प्रति माह मूल्य परिवर्तन: -1.67% (2.39)
3 महीने में कीमत में बदलाव: -22.19% (3.0201)
छह महीने में कीमत में बदलाव: -21.67% (3)
प्रति वर्ष मूल्य परिवर्तन: -24.68% (3.12)
3 वर्षों में मूल्य परिवर्तन: +201.28% (0.78)
5 वर्षों में मूल्य परिवर्तन: -0.4237% (2.36)
वर्ष की शुरुआत से मूल्य परिवर्तन: -22.19% (3.0201)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0.1067 10
P/BV 0.477 10
P/E 0 0
EV/EBITDA -0.0219 0
कुल: 6.25

क्षमता

नाम अर्थ श्रेणी
ROA, % -38.1 0
ROE, % -43.28 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.012 10
कुल: 9.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 727.43 10
लाभप्रदता Ebitda, % 32.22 5
लाभप्रदता EPS, % -91.16 0
कुल: 3.4

संस्थानों आयतन शेयर करना, %
Bml Capital Management, LLC 269839 3.25
Vanguard Group Inc 176965 2.13
Renaissance Technologies, LLC 97222 1.17
Blackrock Inc. 56250 0.68
Geode Capital Management, LLC 43390 0.52
Susquehanna International Group, LLP 33749 0.41
State Street Corporation 14348 0.17
Citadel Advisors Llc 14131 0.17
Cook Wealth Management Group LLC 12175 0.15
HighTower Advisors, LLC 10044 0.12



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. President, CEO & Director 1.16M 1957 (68 साल)
Dr. Kristen K. Buck M.D. Executive VP of R&D and Chief Medical Officer 938.42k 1974 (51 वर्ष)
Mr. James Nisco Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer N/A 1971 (54 वर्ष)
Mr. Tariq Imam Vice President of Business Development & Operations and Corporate Counsel N/A
Mr. Gregory S. Berkin Chief Information Officer N/A
Mr. John D. Menditto Vice President of Investor Relations & Corporate Communications N/A
Ms. Gail Holler Vice President of Human Resources N/A 1959 (66 साल)
Dr. William K. Sietsema Ph.D. Vice President of Global Regulatory Affairs 350.55k 1956 (69 साल)

पता: United States, Basking Ridge. NJ, 110 Allen Road - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.lisata.com